Epigenetics of Thyroid Cancer
Author:
Mohammadi-Asl Javad
Publisher
Springer Netherlands
Reference83 articles.
1. Akagi T, Luong Q, Gui D, Said J, Selektar J, Yung A, Bunce C, Braunstein G, Koeffler H (2008) Induction of sodium iodide symporter gene and molecular characterisation of HNF3β/FoxA2, TTF-1 and C/EBPβ in thyroid carcinoma cells. Br J Cancer 99(5):781–788 2. Alvarez-Nuñez F, Bussaglia E, Mauricio D, Ybarra J, Vilar M, Lerma E, Leiva Ad, Matias-Guiu X (2006) PTEN promoter methylation in sporadic thyroid carcinomas. Thyroid 16(1):17–23 3. Ball E, Bond J, Franc B, DeMicco C, Wynford-Thomas D (2007) An immunohistochemical study of p16 INK4a expression in multistep thyroid tumourigenesis. Eur J Cancer 43(1):194–201 4. Barroeta JE, Baloch Z, Lal P, Pasha TL, Zhang PJ, LiVolsi V (2006) Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol 17:225–234 5. Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M (2007) Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. J Surg Res 143(2):422–427
|
|